ADRIATIC: A phase III trial of durvalumab +/- tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer

Schulz, Christian and Senan, S. and Shire, N. and Mak, G. and Yao, W. and Reinmuth, N. (2021) ADRIATIC: A phase III trial of durvalumab +/- tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 01.-04. Oktober 2021, Berlin, Germany.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Poster)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Klinische Studien
Depositing User: Petra Gürster
Date Deposited: 01 Dec 2022 09:22
Last Modified: 01 Dec 2022 09:22
URI: https://pred.uni-regensburg.de/id/eprint/46822

Actions (login required)

View Item View Item